摘要 |
<p>This patent presents evidence that Mogroside IV.Mogroside V and combinations thereof act as a Toll -Like Receptor -4 agonist and immune stimulant that can be utilized for both therapeutic vaccine design in cancer and for other pathogenic agents. Therapy with Mogroside IV. Mogroside V and combinations thereof are also presented to created immune clearance of a viral infection.</p> |